Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.03
Delayed Data
As of Jun 20
 -0.16 / -3.08%
Today’s Change
3.92
Today|||52-Week Range
8.38
+8.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues15.1M15.0M18.7M21.8M
 
 
 
 
 
Cost of Goods Sold5.0M6.7M8.0M10.0M
 
 
 
 
 
Depreciation And Amortization230.0K230.0K248.0K252.0K
 
 
 
 
 
 
Operating ExpensesGross Income9.9M8.1M10.4M11.5M
 
 
 
 
 
General Expenses33.8M31.8M41.4M34.2M
 
 
 
 
 
Research And Development9.0M9.3M12.6M8.4M
 
 
 
 
 
Total Operating Expenses39.0M38.7M49.7M44.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.9M-23.7M-31.0M-22.8M
 
 
 
 
 
Extraordinary Credit225.0K0.004.8M0.00
 
 
 
Interest Expense On Debt63.0M0.000.00--
 
 
Other Expenses-5.0K1.0K-4.7M21.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-86.5M-23.5M-30.7M-22.5M
 
 
 
 
 
Income Taxes-20.0K-20.0K-295.0K-634.0K
 
 
 
 
 
Net Income-86.5M-23.5M-30.4M-21.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS112.6M119.0M119.2M119.8M
 
 
 
 
 
Shares To Calculate EPS Diluted112.6M119.0M119.2M119.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.77-$0.20-$0.26-$0.18
 
 
 
 
 
EPS Diluted-$0.77-$0.20-$0.26-$0.18